Pregnancy
60 articles on Pregnancy, researched and written by the Shotlee Editorial Team from primary sources.
Doctors Warn a New GLP-1 Finding May Raise Your Risk of Smell Loss
Researchers analyzed nearly 877,000 patients and found a significant link between GLP-1 receptor agonists and sensory disturbances.
8 min read
Meghan McCain Responds to 'Old and Ugly' Comments by Rejecting Ozempic
Meghan McCain has publicly pushed back against harsh online comments about her appearance, emphasizing her commitment to natural aging and rejecting the use of weight-loss medications like Ozempic.
6 min read
Ozempic Face and Hair Loss: Evidence for GLP-1 Drug Side Effects
Weight-loss medications like Wegovy and Mounjaro have surged in popularity, leading to increased discussions about their side effects. This article delves into the scientific evidence for frequently reported concerns such as 'Ozempic face,' hair thinning, digestive problems, and eye conditions associated with GLP-1 agonists.
11 min read
Amy Schumer Shows Off Ongoing Weight Loss, Says C-Section Scar Makes Her a 'Warrior'
Comedian Amy Schumer discusses her 50-pound weight loss journey, Cushing syndrome diagnosis, and C-section recovery in a candid new update.
10 min read
Amy Schumer Highlights C-Section Scar After Weight Loss Journey: 'I'm a Warrior'
Amy Schumer, known for her candidness, recently shared a powerful image highlighting her C-section scar, a testament to her strength and resilience throughout her health and weight loss journey.
6 min read
Amy Schumer Reveals Ongoing Weight Loss in New Selfie, Says C-Section Scar Makes Her a 'Warrior'
Comedian Amy Schumer recently shared a selfie highlighting her weight loss and C-section scar, opening up about her diagnosis of Cushing's syndrome and her path to health.
7 min read
Ozempic & Wegovy Online: The Risky Rush to Bypass Doctor Consultations
The surge in GLP-1 medications for weight loss has led to a concerning trend: many online pharmacies are prescribing these powerful drugs with minimal to no doctor consultation, putting patients at significant risk.
6 min read
Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure
GLP-1 receptor agonists, known for their role in diabetes and weight management, are increasingly recognized for their broader health benefits, including effects on blood pressure. This article delves into how these medications work, their impact on cardiovascular health, and whether they are safe for individuals with hypertension.
8 min read
Semaglutide and Pregnancy: Understanding New Risks and Weight Rebound
A recent national database study reveals significant obstetric risks associated with semaglutide exposure before and during pregnancy, highlighting the importance of the weight rebound effect.
7 min read
Beyond BMI: Hidden Health Reasons Doctors May Decline Mounjaro or Wegovy
While BMI is a primary factor, a range of underlying health conditions and personal histories can lead to a doctor declining a prescription for popular weight loss medications like Mounjaro and Wegovy. Understanding these criteria is vital before seeking treatment.
7 min read
Beyond BMI: Why Mounjaro Eligibility is More Complex Than You Think
Many assume BMI is the sole determinant for Mounjaro prescriptions, but the reality is far more nuanced. This article explores the comprehensive health criteria healthcare providers use to ensure safe and effective treatment.
6 min read
Beyond the 'Bridal Glow': The Real Story of Mounjaro & Weight Loss
As 'Mounjaro brides' become a trend, an endocrinologist unpacks the medical realities, risks, and ethical concerns surrounding using powerful weight-loss medications for cosmetic pre-wedding transformations.
9 min read
GLP-1 Medications: Understanding Drug Interactions and Safety
GLP-1 receptor agonists are powerful tools for managing diabetes and obesity, but understanding their potential interactions with other medications is crucial for patient safety and treatment efficacy.
7 min read
GLP-1 Drugs: Beyond Weight Loss – New Benefits and Risks Emerge
GLP-1 medications are revolutionizing weight management and diabetes care, but their impact extends far beyond the scale. This article delves into the emerging benefits and potential risks associated with these powerful drugs, offering a comprehensive overview for patients and healthcare providers.
8 min read
GLP-1s and Pregnancy: New Study Offers Cautious Reassurance
New research from the University of St Andrews offers a glimmer of hope for individuals using GLP-1 medications who become pregnant. This comprehensive review of nearly 50,000 pregnancies suggests a potentially lower risk of adverse outcomes than previously feared, though experts emphasize caution.
7 min read
GLP-1 Medications & Weight Loss: What's Behind the Buzz?
The world of weight management has been significantly impacted by the emergence of GLP-1 receptor agonists. These medications, including popular drugs like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro), have garnered immense attention for their effectiveness in promoting weight loss and improving metabolic health. But what exactly are these drugs, how do they work, and what should individuals considering them know?
7 min read
Shaughna Phillips' Weight Loss Journey: Body Positivity Amid Cellulite & Lipo...
Love Island star Shaughna Phillips is celebrating a 9kg weight loss over four months, sharing transparent before-and-after videos despite cellulite and lipoedema flare-ups. Rejecting Ozempic claims, she credits gym sessions, protein-focused eating, and her Shred It Plan. Her journey emphasizes progress over perfection for busy moms.
6 min read
Claudia Oshry on 'Relief' Restarting GLP-1s After Pregnancy & Low-Lift Hacks
Claudia Oshry is candid about restarting GLP-1 medications after welcoming son Reuben, calling it a 'relief' that helped her stay present during pregnancy and breastfeeding. The Toast host loves low-lift wellness like water, electrolytes, sun, and Dulcolax gummies for gut health. Now embracing her postpartum body, she blocks GLP-1 criticism amid life-changing results.
6 min read
Investors' Ozempic Mania Could Harm Health Priorities
Institutional investors have sidelined climate change in ESG priorities, favoring health tech fueled by Ozempic and GLP-1 drugs. A Berenberg Bank survey of 200 investors ranks health first as climate slips to fifth. Yet, climate change poses severe health threats from heatwaves to vector-borne diseases—why this mania could backfire.
4 min read
Wegovy Pill Cost: Get It for $149/Month via WeightWatchers Med+
The new FDA-approved Wegovy pill is now available at just $149 per month for starter doses via WeightWatchers Med+, making GLP-1 weight loss therapy more affordable. This self-pay pricing beats typical injectable costs, but it's limited to 1.5mg and 4mg doses for the first four months. Discover eligibility, comparisons, and how to get started before the offer ends April 15.
5 min read
What to Know If Taking Weight Loss Drugs Like Ozempic
Roughly half a million Australians are using GLP-1 weight loss drugs like Ozempic and Mounjaro, with some reporting life-changing results while others face side effects. Professor Kelly Lambert from the University of Wollongong shares key insights on what you need to know. This guide covers mechanisms, safety, and practical tips for users.
5 min read
Cardiologist Sues UPMC; BP Control Stagnant; GLP-1 in Pregnancy
A prominent cardiologist has filed a whistleblower lawsuit against UPMC alleging racist texts and CEO conflicts. Meanwhile, U.S. blood pressure control remains below pre-pandemic levels, per new data. GLP-1 drugs during pregnancy show promising maternal benefits with no rise in fetal risks, according to a meta-analysis.
6 min read
GLP-1 Weight Loss Consistent Across Race, Age, BMI—But Not Sex
GLP-1 receptor agonists like semaglutide show consistent weight loss efficacy across diverse groups, but a notable sex difference emerges: women average 10.9% body weight loss versus 6.8% for men. This JAMA meta-analysis reassures clinicians while highlighting areas for further research. Experts explain why this matters for personalized obesity care.
5 min read
FDA Approves Foundayo: GLP-1 Weight Loss Pill with Fewer Use Restrictions
Eli Lilly's Foundayo, a new GLP-1 weight loss pill, just received FDA approval with key advantages: take it anytime without food or water restrictions. Backed by trials showing 12% body weight loss over 72 weeks, it aims to make obesity treatment more accessible. Compare pricing, side effects, and how it stacks up against Wegovy and injectables.
5 min read
How Next CDC Director Can Restore America's Public Trust
Five years post-COVID peak, America's trust in the CDC has plummeted amid testing delays, poor communication, and policy missteps. Experts outline six critical reforms for the next director to refocus the agency on infectious threats while addressing chronic diseases. Restoring credibility is essential before the next pandemic strikes.
5 min read
Telangana Warns on Semaglutide Misuse for Weight Loss
Telangana's Drugs Control Administration has issued a stark warning against misusing Semaglutide formulations for weight loss without medical oversight. With patent expiry looming in March 2026, multiple versions are flooding the market, raising safety concerns. Improper use risks serious complications like pancreatitis and gastrointestinal disorders.
5 min read
Lost 6 Stone on Mounjaro: Best Side Effect No One Talks About
Single mum Rebecca Tidy transformed her life by losing six stone on Mounjaro, but the real game-changer was the confidence boost that doubled her income. After ditching Saxenda due to side effects, Mounjaro helped her reclaim control. Here's her inspiring journey from exhaustion to empowerment.
7 min read
Ozempic and Wegovy Linked to Reduced Anxiety and Depression Risk
Semaglutide, the active ingredient in Ozempic and Wegovy, is associated with a 44% decreased risk of worsening depression and 38% lower anxiety risk, per a large Swedish study. Researchers suggest potential neurobiological effects beyond weight loss. Discover how these GLP-1 agonists may support mental health in diabetes and obesity patients.
5 min read
Weight Loss Injections Side Effects Affect 1 in 10 Users
Weight loss injections such as Mounjaro and Wegovy, popular GLP-1 inhibitors, come with side effects impacting one in 10 users, primarily digestive issues like nausea and diarrhea. The British Heart Foundation highlights risks including pancreatitis, vision loss, and nutritional deficiencies. Understanding these helps patients manage treatment safely.
5 min read
Rachel Weisz in Vladimir Captures Midlife Libido Explosion from HRT & GLP-1s
Netflix's Vladimir stars Rachel Weisz as a 56-year-old consumed by desire, echoing a secret midlife libido explosion many women are experiencing. Attributed to surging HRT use and GLP-1 weight loss injections, this trend is reshaping confidence and relationships. From cultural hits to real-life chats, explore why midlife women feel hotter than ever.
4 min read
Semaglutide Could Cost as Little as $28/Year by End of 2026
Semaglutide, the powerhouse behind Ozempic and Wegovy, might soon become dramatically more affordable. A recent study reveals generic versions could cost as little as $28 per person-year after patents expire in 2026. This could transform access to treatment for obesity and type 2 diabetes globally.
5 min read
Burn Slim Exposed: Real Users Reveal GLP-1 Mimetic Effects
Burn Slim Capsules are gaining attention as a natural GLP-1 mimetic alternative to prescription drugs like semaglutide. Real users report dramatic appetite changes, consistent fat loss up to 22 pounds in 12 weeks, and sustained results without muscle loss or loose skin. Backed by studies on its four key ingredients, this guide exposes the science and user truths.
6 min read
Aspen Plans Mounjaro Rollout in Sub-Saharan Africa
South Africa's Aspen Pharmacare is accelerating Mounjaro's rollout across sub-Saharan Africa after its explosive success at home, where the GLP-1 market tripled to $133.6 million. With over half the market share and $78.97 million in projected sales, this expansion tests rapid access to advanced weight-loss therapies. Here's how Aspen's KwikPen approval paves the way.
4 min read
Jessica Simpson's Changing Appearance Sparks 'Ozempic Face' Debate
Jessica Simpson, the 45-year-old star who rose to fame at 19 with 'I Wanna Love You Forever,' has fans buzzing over her transformed appearance. Speculation points to 'Ozempic face'—sunken eyes, sagging skin from GLP-1 drugs—but Simpson insists it's all willpower and healthy habits after losing 100 pounds post-pregnancy.
5 min read
Hair Loss, Bloating, Regret: Dangers of DIY Ozempic Jabs
Elfina lost 3kg in two weeks on DIY Ozempic but faced clumps of hair falling out, leading to regret. Nafisa stopped after one jab due to painful bloating. This exclusive look reveals the perils of bypassing medical supervision for Semaglutide.
5 min read
Millennial Stars Admit to Ozempic & GLP-1 Use: Transformations
Midlife weight gain is hitting millennial stars hard, but many are turning to Ozempic and other GLP-1s for help. Celebrities including Amy Schumer, Golnesa 'GG' Gharachedaghi, and Serena Williams have openly admitted to using these medications, sharing their triumphs, side effects, and transformations. Discover their stories and the science behind these popular drugs.
5 min read
Ozempic and Metformin: Similarities After Side Effect Warnings
Ozempic and metformin are both widely used for Type 2 diabetes management, sharing benefits like blood sugar control and potential weight loss effects, but recent side effect warnings highlight their overlaps and differences. While metformin serves 120 million people worldwide as a daily tablet, Ozempic is a weekly injection for adults. Understand why consulting your doctor is essential before switching.
6 min read
Heart Disease in Women Projected to Rise 34% by 2050, AHA Warns
Without improved prevention, cardiovascular disease rates in U.S. women could climb from 10.7% in 2020 to 14.4% in 2050, warns the American Heart Association. Rising obesity, diabetes, and high blood pressure are key drivers, especially among younger women and underserved groups. Experts call for urgent action on early detection and lifestyle changes.
7 min read
GP's Surprising Mounjaro Effects: Weight Loss and Mood Shifts After 3 Months
A 33-year-old GP tried Mounjaro for obesity and was stunned by more than just weight loss—his 'food noise' vanished, alcohol interest dropped, and mood stabilized. After shedding almost two stone in three months, urges returned upon stopping, highlighting obesity's chronic nature. Now back on 5mg, he emphasizes long-term strategies beyond medication.
5 min read
Leicester Doctor's Mounjaro Experience: Mental Changes & Advice
A Leicester doctor tried Mounjaro for obesity and was shocked by how it silenced his 'food noise' and curbed alcohol desires, alongside significant weight loss. But stopping brought cravings back fast. Discover his message on long-term use, side effects, and who should consider it.
5 min read
In-Depth Analysis: Gonadorelin 5mg Research Peptide Use
Gonadorelin 5mg research peptide is gaining traction in studies of hormonal health and reproductive medicine. This synthetic GnRH mimic helps researchers investigate gonadotropin release, hormonal imbalances, and therapies for conditions like hypogonadism. Delve into its mechanisms, efficacy metrics, and essential ethical considerations for robust clinical research.
5 min read
American Girl Dolls Get 'Ozempic' Makeover for Modern Era, Public Unimpressed
American Girl Dolls have undergone a controversial 'Ozempic' makeover, with slimmer bodies aimed at the 'modern era'—but many parents and influencers are far from impressed. The redesign highlights the cultural impact of GLP-1 medications like Ozempic on body ideals. Explore the debate, drug mechanisms, and health considerations.
5 min read
Intermittent Fasting No Better for Weight Loss Than Dieting, Cochrane Review ...
New Cochrane research reveals intermittent fasting offers no weight loss advantage over traditional dietary advice or even no intervention at all. Analyzing 22 studies with 1,995 overweight or obese adults, the review highlights similar outcomes across groups. Discover the details and potential benefits beyond the scale.
5 min read
Kelly Osbourne's 'Ozempic Face' Photos Alarm Fans Despite Denial
Kelly Osbourne stunned fans with her ultra-thin look at the 2026 Grammy Awards, reigniting 'Ozempic face' rumors despite her firm denial of using the drug. After losing 85 pounds through cutting sugar and carbs following gestational diabetes, public skepticism grows amid her skeletal appearance. Discover the story behind the transformation and medical insights on rapid weight loss effects.
6 min read
Soha Ali Khan Reacts to Aishwarya Mohanraj's Mounjaro Weight Loss Reveal
Comedian and influencer Aishwarya Mohanraj bravely shared that weekly Mounjaro injections helped her shed 22kg in just 6 months, from 74kg to 52kg, overcoming deep insecurities. Soha Ali Khan commended her candor, saying 'so finally someone said it' in an industry rife with simplified transformation tales. Learn the details and what Mounjaro means for weight loss.
5 min read
Weight-Loss Drugs Compete in Super Bowl Ads: Wegovy Leads
Weight-loss drugs like Wegovy's new pill are making a splash with multimillion-dollar Super Bowl ads featuring Kenan Thompson, DJ Khaled, and Serena Williams. As Novo Nordisk and Eli Lilly battle for market share, affordable oral GLP-1 options starting at $49 signal a new era in obesity care. See how these celebrity spots aim to reach 130 million viewers.
5 min read
Serena Williams Weight Loss: GLP-1 Transformation Revealed
Tennis icon Serena Williams has shared her inspiring weight loss story, dropping 34 pounds with GLP-1 drugs after struggling post-retirement and motherhood. Facing unknown heart disease risks, she credits the medication with transforming her health. Inside her journey and how GLP-1 works for real results.
5 min read
GLP-1 Drugs & Fertility: Surprising Pregnancies on Mounjaro, Ozempic
Women on GLP-1 drugs like tirzepatide and semaglutide are reporting surprise pregnancies after significant weight loss. This guide explains the mechanisms, emerging trends, and essential precautions for those on these medications considering family planning.
5 min read
Oral Wegovy: Benefits, Dosing, and What Patients Need to Know
Novo Nordisk's oral Wegovy has launched with impressive prescription volumes, offering a pill alternative to injections for weight management. Learn about its efficacy, ideal candidates, dosing, and how it fits into GLP-1 therapy. This guide breaks down the science and practical advice for patients.
5 min read
Mounjaro Gallbladder Risks: Real Patient Story & Expert Guide
Emma lost 8 stone on Mounjaro but faced a life-threatening gallbladder crisis. Her story highlights rising GLP-1 side effects like gallstones amid surging UK surgeries. This guide unpacks the risks, science, and how to protect your health.
4 min read
GLP-1 Side Effects & Lawsuits: What Users Must Know
GLP-1 medications like Ozempic and Wegovy have transformed weight management, but rising lawsuits highlight serious side effects like gastroparesis and vision loss. This guide breaks down the science, risks, and strategies for safe use. Learn how to monitor symptoms and integrate lifestyle changes effectively.
4 min read
Ozempic: Benefits, Risks & the Science of GLP-1 Drugs
Ozempic has transformed weight loss, but is it too good to be true? Galway author Aimee Donnellan's 'Off the Scales' uncovers the science, overlooked pioneers, and real patient stories behind GLP-1 injections. Discover the benefits, serious risks like muscle loss, and what happens when you stop.
5 min read
GLP-1 News 2025: Safety Alerts, Fakes & Breakthroughs
GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound now make up over 7% of U.S. prescriptions, fueling weight loss trends but raising safety concerns. From FDA warnings on sharing pens to charges over fake drugs, here's what patients need to know. Discover emerging research and tools to manage your therapy safely.
4 min read
Ozempic Weight Loss: Amanda Bynes' 28lb Transformation Explained
Amanda Bynes recently shared her 28-pound weight loss journey on Ozempic, dropping from 180lbs to 152lbs and feeling inspired. This celebrity story highlights the growing popularity of GLP-1 medications for weight management. Learn the science, evidence, and practical advice behind these powerful tools.
4 min read
WHO's Shift: GLP-1 Drugs Transform Obesity Treatment
The WHO has issued landmark guidelines endorsing GLP-1 receptor agonists for obesity treatment, marking a pivotal shift from lifestyle-only approaches. These drugs, including semaglutide and tirzepatide, offer substantial weight loss but come with cautions on long-term safety. This guide unpacks the science, evidence, and practical implications for patients.
4 min read
Novo Nordisk GLP-1s: Ozempic, Wegovy, Rybelsus Guide
Novo Nordisk has redefined obesity and diabetes care with its GLP-1 powerhouse: semaglutide brands Ozempic, Wegovy, and Rybelsus. These injectables and oral options deliver substantial weight loss, glycemic control, and cardiovascular protection. Discover how they work, compare to competitors, and optimize your treatment.
4 min read
Naltrexone: Ozempic for Alcohol Cravings Explained
Naltrexone is gaining buzz as the 'Ozempic for alcohol' by blunting booze's euphoric reward, much like GLP-1 drugs curb food noise. This guide dives into its science, real-world use via the Sinclair Method, and clinical evidence for reducing intake. Learn if it's right for habitual drinkers aiming for moderation.
4 min read
GLP-1 Drugs: Weight Loss Benefits & Fertility Risks for Women
GLP-1 receptor agonists excel in weight management and glucose control, but their effects on women's reproductive health demand attention. These drugs can restore ovulation in obese women with insulin resistance, yet they risk unplanned pregnancies and are unsafe during gestation. Consult experts before use.
3 min read
Novo Nordisk's 'There's Only One Ozempic' Campaign Reunites Stars
Novo Nordisk introduces the 'There's Only One Ozempic' campaign, reuniting comedy duo Justin Long and John Hodgman to spotlight Ozempic's unique FDA-approved benefits for type 2 diabetes. The effort uses humor and education to distinguish genuine Ozempic (semaglutide) from unapproved compounded versions. It encourages vital conversations between patients and healthcare providers.
5 min read
Understanding GLP-1 Drugs for Weight Loss & Diabetes
GLP-1 drugs mimic natural hormones to reduce hunger, slow digestion, and control blood sugar, aiding weight loss and type 2 diabetes. In Malaysia, over 54% of adults are overweight or obese, prompting Health Ministry rollout for vulnerable groups in 2026. Understand benefits, risks, and safe use guidelines.
3 min read